PortfoliosLab logoPortfoliosLab logo
ONC vs. KOF
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ONC vs. KOF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BeOne Medicines Ltd (ONC) and Coca-Cola FEMSA, S.A.B. de C.V. (KOF). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ONC achieves a -1.68% return, which is significantly lower than KOF's 11.19% return. Over the past 10 years, ONC has outperformed KOF with an annualized return of 26.05%, while KOF has yielded a comparatively lower 6.55% annualized return.


ONC

1D
-1.36%
1M
12.94%
6M
-11.60%
YTD
-1.68%
1Y
19.34%
3Y*
16.68%
5Y*
-1.93%
10Y*
26.05%

KOF

1D
0.69%
1M
-4.37%
6M
6.96%
YTD
11.19%
1Y
21.72%
3Y*
12.92%
5Y*
19.36%
10Y*
6.55%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ONC vs. KOF - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ONC
BeOne Medicines Ltd
-1.68%64.48%2.41%-18.00%-18.82%4.85%55.88%18.18%43.53%221.87%
KOF
Coca-Cola FEMSA, S.A.B. de C.V.
11.19%27.03%-14.60%45.09%29.83%24.85%-19.17%2.46%-9.99%12.36%

Correlation

The correlation between ONC and KOF is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (10Y)
Calculated over the trailing 10-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Feb 3, 2016

0.14

Fundamentals

Market Cap

ONC:

$31.92B

KOF:

$21.89B

EPS

ONC:

$4.48

KOF:

MX$36.18

PE Ratio

ONC:

66.71

KOF:

50.48

PS Ratio

ONC:

5.96

KOF:

3.97

PB Ratio

ONC:

7.26

KOF:

22.20

Total Revenue (TTM)

ONC:

$5.74B

KOF:

MX$293.49B

Gross Profit (TTM)

ONC:

$5.07B

KOF:

MX$135.01B

EBITDA (TTM)

ONC:

$954.09M

KOF:

MX$41.79B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ONC vs. KOF — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ONC
ONC Risk / Return Rank: 5858
Overall Rank
ONC Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
ONC Sortino Ratio Rank: 5858
Sortino Ratio Rank
ONC Omega Ratio Rank: 5656
Omega Ratio Rank
ONC Calmar Ratio Rank: 5959
Calmar Ratio Rank
ONC Martin Ratio Rank: 5959
Martin Ratio Rank

KOF
KOF Risk / Return Rank: 6969
Overall Rank
KOF Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
KOF Sortino Ratio Rank: 6868
Sortino Ratio Rank
KOF Omega Ratio Rank: 6565
Omega Ratio Rank
KOF Calmar Ratio Rank: 6969
Calmar Ratio Rank
KOF Martin Ratio Rank: 7171
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ONC vs. KOF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BeOne Medicines Ltd (ONC) and Coca-Cola FEMSA, S.A.B. de C.V. (KOF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ONCKOFDifference
Sharpe ratioReturn per unit of total volatility

-0.41

Sortino ratioReturn per unit of downside risk

-0.46

Omega ratioGain probability vs. loss probability

1.11

1.16

-0.05

Calmar ratioReturn relative to maximum drawdown

0.58

1.17

-0.59

Martin ratioReturn relative to average drawdown

1.17

3.01

-1.84

ONC vs. KOF - Sharpe Ratio Comparison

The current ONC Sharpe Ratio is 0.44, which is lower than the KOF Sharpe Ratio of 0.85. The chart below compares the historical Sharpe Ratios of ONC and KOF, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ONC vs. KOF - Drawdown Comparison

The maximum ONC drawdown since its inception was -69.96%, smaller than the maximum KOF drawdown of -74.81%. Use the drawdown chart below to compare losses from any high point for ONC and KOF.


Loading charts...

Drawdown Indicators


ONCKOFDifference

Max Drawdown

Largest peak-to-trough decline

-69.96%

-74.81%

+4.85%

Max Drawdown (1Y)

Largest decline over 1 year

-31.05%

-18.13%

-12.92%

Max Drawdown (3Y)

Largest decline over 3 years

-42.47%

-24.50%

-17.97%

Max Drawdown (5Y)

Largest decline over 5 years

-69.96%

-24.50%

-45.46%

Max Drawdown (10Y)

Largest decline over 10 years

-69.96%

-55.04%

-14.92%

Current Drawdown

Current decline from peak

-25.91%

-8.06%

-17.85%

Average Drawdown

Average peak-to-trough decline

-29.62%

-28.96%

-0.66%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.36%

7.06%

+8.30%

Volatility

ONC vs. KOF - Volatility Comparison

BeOne Medicines Ltd (ONC) has a higher volatility of 8.45% compared to Coca-Cola FEMSA, S.A.B. de C.V. (KOF) at 6.85%. This indicates that ONC's price experiences larger fluctuations and is considered to be riskier than KOF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ONCKOFDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.45%

6.85%

+1.60%

Volatility (6M)

Calculated over the trailing 6-month period

25.65%

18.85%

+6.80%

Volatility (1Y)

Calculated over the trailing 1-year period

40.49%

24.89%

+15.60%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

56.20%

24.37%

+31.83%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

55.60%

25.86%

+29.74%

Dividends

ONC vs. KOF - Dividend Comparison

ONC has not paid dividends to shareholders, while KOF's dividend yield for the trailing twelve months is around 3.91%.


PositionTTM20252024202320222021202020192018201720162015
KOF
Coca-Cola FEMSA, S.A.B. de C.V.
3.91%4.09%4.20%3.37%3.99%4.59%5.22%2.75%2.95%2.52%2.84%2.74%
ONC
BeOne Medicines Ltd
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ONC vs. KOF - Financials Comparison

This section allows you to compare key financial metrics between BeOne Medicines Ltd and Coca-Cola FEMSA, S.A.B. de C.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
1.51B
70.93B
(ONC) Total Revenue
(KOF) Total Revenue
Please note, different currencies. ONC values in USD, KOF values in MXN

ONC vs. KOF - Profitability Comparison

The chart below illustrates the profitability comparison between BeOne Medicines Ltd and Coca-Cola FEMSA, S.A.B. de C.V. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
89.0%
46.9%
Portfolio components
ONC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, BeOne Medicines Ltd reported a gross profit of 1.35B and revenue of 1.51B. Therefore, the gross margin over that period was 89.0%.

KOF - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Coca-Cola FEMSA, S.A.B. de C.V. reported a gross profit of 33.26B and revenue of 70.93B. Therefore, the gross margin over that period was 46.9%.

ONC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, BeOne Medicines Ltd reported an operating income of 249.90M and revenue of 1.51B, resulting in an operating margin of 16.5%.

KOF - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Coca-Cola FEMSA, S.A.B. de C.V. reported an operating income of 9.03B and revenue of 70.93B, resulting in an operating margin of 12.7%.

ONC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, BeOne Medicines Ltd reported a net income of 227.36M and revenue of 1.51B, resulting in a net margin of 15.0%.

KOF - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Coca-Cola FEMSA, S.A.B. de C.V. reported a net income of 4.34B and revenue of 70.93B, resulting in a net margin of 6.1%.


Frequently Asked Questions


ONC and KOF have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ONC has higher volatility (8.45%) compared to KOF (6.85%). In terms of maximum drawdown, ONC dropped -69.96% vs KOF's -74.81%.

KOF currently has the higher Sharpe Ratio (0.85 vs 0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ONC and KOF

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer